A decentralised point-of-care testing model to address inequities in the COVID-19 response
- PMID: 33357517
- PMCID: PMC7758179
- DOI: 10.1016/S1473-3099(20)30859-8
A decentralised point-of-care testing model to address inequities in the COVID-19 response
Erratum in
-
Correction to Lancet Infect Dis 2020; published online Dec 23. https://doi.org/10.1016/S1473-3099(20)30859-8.Lancet Infect Dis. 2021 Jul;21(7):e182. doi: 10.1016/S1473-3099(21)00326-1. Lancet Infect Dis. 2021. PMID: 34174241 Free PMC article. No abstract available.
Abstract
The COVID-19 pandemic is growing rapidly, with over 37 million cases and more than 1 million deaths reported by mid-October, 2020, with true numbers likely to be much higher in the many countries with low testing rates. Many communities are highly vulnerable to the devastating effects of COVID-19 because of overcrowding in domestic settings, high burden of comorbidities, and scarce access to health care. Access to testing is crucial to globally recommended control strategies, but many communities do not have adequate access to timely laboratory services. Geographic dispersion of small populations across islands and other rural and remote settings presents a key barrier to testing access. In this Personal View, we describe a model for the implementation of decentralised COVID-19 point-of-care testing in remote locations by use of the GeneXpert platform, which has been successfully scaled up in remote Aboriginal and Torres Strait Islander communities across Australia. Implementation of the decentralised point-of-care testing model should be considered for communities in need, especially those that are undertested and socially vulnerable. The decentralised testing model should be part of the core global response towards suppressing COVID-19.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Figures
Comment in
-
Border screening is an essential component of COVID-19 testing strategies in Vanuatu.Lancet Infect Dis. 2021 Jun;21(6):769-770. doi: 10.1016/S1473-3099(21)00135-3. Epub 2021 Mar 8. Lancet Infect Dis. 2021. PMID: 33705728 Free PMC article. No abstract available.
References
-
- WHO Coronavirus disease (COVID-19) weekly epidemiological update. Oct 12, 2020. https://www.who.int/publications/m/item/weekly-epidemiological-update---...
-
- Our World in Data Cumulative confirmed COVID-19 cases per million people. https://ourworldindata.org/coronavirus-data-explorer?country=USA~GBR~CAN...
-
- Australian Government Department of Health COVID-19 Australia: epidemiology report 26. Commun Dis Intell. 2020;44
